Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Animal rabies virus and vaccine and production method thereof

A rabies virus and production method technology, applied in the field of biological products, can solve the problems of no special and effective treatment for rabies, large batch differences, unstable quality, etc., to achieve uniform and stable product quality, small batch differences, and single batch. high yield effect

Active Publication Date: 2011-02-23
PULIKE BIOLOGICAL ENG INC
View PDF5 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no specific and effective treatment for rabies, and injection of rabies antigen is the only effective method
[0003] At present, the rabies vaccines on the market are basically subcultured by the spinner bottle process. Large-scale production requires a lot of material and human resources, and the cost is high, and the difference between batches is large, and the quality is unstable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Animal rabies virus and vaccine and production method thereof
  • Animal rabies virus and vaccine and production method thereof
  • Animal rabies virus and vaccine and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The production method of embodiment 1 rabies vaccine

[0048] 1. Viruses and cell lines

[0049] The virus strain used to prepare the rabies vaccine is the LEP-Flury strain, and the pathogenicity test shows that the virus of this strain is not pathogenic. The hamster kidney cell (BHK21), a cell line with good sensitivity to the virus strain, is used as the cell line for vaccine production, so as to infect and multiply the rabies virus in large quantities.

[0050] 2. Preparation method

[0051] (1) Inoculate the cell line hamster kidney cells (BHK21) used for the preparation of the vaccine into DMEM liquid medium (comprising 5% bovine serum, 2.2g / L NaHCO 3 , 50IU / ml kanamycin sulfate (kanamycin sulfate), 100IU / ml penicillin G sodium salt (Penicillin G Sodium), pH value is 7.2) and in the carrier tank of polyester fiber microcarrier; microcarrier density is 60g / L , the initial inoculum size of cells was 2.7×10 7 cells / g microcarriers.

[0052] (2) At 37°C, 5% CO 2 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for producing animal rabies viruses and animal rabies vaccines on a large scale. By using a bioreactor, the animal rabies viruses and the animal rabies vaccines are produced by a cell micro-carrier suspension culturing system on a large scale by the following steps of: inoculating cells for preparing the vaccine into a carrier tank containing culture solution and micro-carriers to attach the cells to the micro-carriers; growing the cells on the micro-carriers until the concentration of culture solution is 5 to 20 times the inoculation concentration under a proper culturing environment; preparing virus suspension from the rabies virus to adsorb the virus suspension to the cells; replacing cell maintenance culture solution to culture the virus under the proper culturing environment; continuously culturing for 3 to 5 days and harvesting the virus solution for the first time, wherein the solution replacement ratio is 50 percent by using a semi-continuous process; continuously culturing for 9 to 11 days and harvesting and replacing the solution once every 24 hours; and mixing the harvested virus solution and the virus solution of the bioreactor, repeatedly performing freeze-thawing twice at the constant temperature of -20 DEG C, inactivating, purifying and adding adjuvants to prepare the rabies vaccine. The method has the advantages of large production scale, high single-batch yield and relatively low production cost.

Description

technical field [0001] The invention relates to a rabies virus and a vaccine for veterinary use and a production method thereof, belonging to the technical field of biological products. Background technique [0002] Rabies is a zoonotic disease caused by rabies virus (Rabies virus, RV) infection with severe symptoms and high fatality rate. The mortality rate is almost 100%. Currently, there is no effective treatment. Wild animals are the main storage hosts of RV. Once people are bitten by such animals carrying rabies virus, they will be infected and diseased, and the case fatality rate is 100%. According to the latest statistics on infectious disease epidemics released by the Ministry of Health, it shows that rabies continues to show signs of danger in recent years. However, there is no specific and effective treatment for rabies, and injection of rabies antigen is the only effective method. [0003] At present, the rabies vaccines on the market are basically subcultured b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P31/14C12N7/04C12N7/00A61K39/205
Inventor 张许科孙进忠乔荣岑
Owner PULIKE BIOLOGICAL ENG INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products